Out-licensing

Messenger Biopharma will not develop its own mRNA products.

We are eager to out-license our Aegis biotechnology to pharmaceutical and biotech companies for vaccine and gene therapy products development.

Last news

photo animalerie 1

OST Group becomes a shareholder in July 2019

posted July 08, 2019

Read More